Hill AV - Search Results

1

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.

Griffiths KL, Pathan AA, Minassian AM, Sander CR, Beveridge NE, Hill AV, Fletcher HA, McShane H. Griffiths KL, et al. Among authors: hill av. PLoS One. 2011;6(8):e23463. doi: 10.1371/journal.pone.0023463. Epub 2011 Aug 26. PLoS One. 2011. PMID: 21887254 Free PMC article.

2

Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.

McShane H, Behboudi S, Goonetilleke N, Brookes R, Hill AV. McShane H, et al. Among authors: hill av. Infect Immun. 2002 Mar;70(3):1623-6. doi: 10.1128/IAI.70.3.1623-1626.2002. Infect Immun. 2002. PMID: 11854254 Free PMC article.

3

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.

McConkey SJ, Reece WH, Moorthy VS, Webster D, Dunachie S, Butcher G, Vuola JM, Blanchard TJ, Gothard P, Watkins K, Hannan CM, Everaere S, Brown K, Kester KE, Cummings J, Williams J, Heppner DG, Pathan A, Flanagan K, Arulanantham N, Roberts MT, Roy M, Smith GL, Schneider J, Peto T, Sinden RE, Gilbert SC, Hill AV. McConkey SJ, et al. Among authors: hill av. Nat Med. 2003 Jun;9(6):729-35. doi: 10.1038/nm881. Epub 2003 May 25. Nat Med. 2003. PMID: 12766765 Clinical Trial.

4

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.

Goonetilleke NP, McShane H, Hannan CM, Anderson RJ, Brookes RH, Hill AV. Goonetilleke NP, et al. Among authors: hill av. J Immunol. 2003 Aug 1;171(3):1602-9. doi: 10.4049/jimmunol.171.3.1602. J Immunol. 2003. PMID: 12874255

5

CD8+ T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages.

Brookes RH, Pathan AA, McShane H, Hensmann M, Price DA, Hill AV. Brookes RH, et al. Among authors: hill av. Eur J Immunol. 2003 Dec;33(12):3293-302. doi: 10.1002/eji.200324109. Eur J Immunol. 2003. PMID: 14635037 Free article.

6

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.

McShane H, Pathan AA, Sander CR, Keating SM, Gilbert SC, Huygen K, Fletcher HA, Hill AV. McShane H, et al. Among authors: hill av. Nat Med. 2004 Nov;10(11):1240-4. doi: 10.1038/nm1128. Epub 2004 Oct 24. Nat Med. 2004. PMID: 15502839 Clinical Trial.

7

Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.

Williams A, Hatch GJ, Clark SO, Gooch KE, Hatch KA, Hall GA, Huygen K, Ottenhoff TH, Franken KL, Andersen P, Doherty TM, Kaufmann SH, Grode L, Seiler P, Martin C, Gicquel B, Cole ST, Brodin P, Pym AS, Dalemans W, Cohen J, Lobet Y, Goonetilleke N, McShane H, Hill A, Parish T, Smith D, Stoker NG, Lowrie DB, Källenius G, Svenson S, Pawlowski A, Blake K, Marsh PD. Williams A, et al. Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):29-38. doi: 10.1016/j.tube.2004.09.009. Epub 2005 Jan 20. Tuberculosis (Edinb). 2005. PMID: 15687025

8

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.

McShane H, Pathan AA, Sander CR, Goonetilleke NP, Fletcher HA, Hill AV. McShane H, et al. Among authors: hill av. Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):47-52. doi: 10.1016/j.tube.2004.09.015. Epub 2005 Jan 21. Tuberculosis (Edinb). 2005. PMID: 15687027 Review.

9

Prime-boost immunisation strategies for tuberculosis.

McShane H, Hill A. McShane H, et al. Microbes Infect. 2005 May;7(5-6):962-7. doi: 10.1016/j.micinf.2005.03.009. Epub 2005 Apr 15. Microbes Infect. 2005. PMID: 15890555 Free article. Review.

10

Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity.

Hutchings CL, Gilbert SC, Hill AV, Moore AC. Hutchings CL, et al. Among authors: hill av. J Immunol. 2005 Jul 1;175(1):599-606. doi: 10.4049/jimmunol.175.1.599. J Immunol. 2005. PMID: 15972697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

844 results

Search Page

Filters